In recent years, considerable advances have been made in our understanding of Parkinson's disease. In particular, information on genetic contributions to disease etiology has expanded and an increased awareness of the incidence and importance of non-motor features. Theories relating to pathogenesis and pathophysiology have been refined and new treatment modalities... read moreimplemented.
This series will cover both preclinical and clinical science, providing a resource for all Parkinson’s disease researchers.
The preclinical section of the series covers the anatomical and biochemical changes associated with Parkinson’s disease as well as the genetic factors which can influence it.
The clinical section of the series covers methods for assessing the progression of Parkinson’s disease (including non-motor symptoms), treatment of patients and likely developments in the future.